In contrast, a nominally significant difference was observed during time window 1 in the sensitivity cohort, a difference that may be an artifact of multiple testing, whereas the lower P value for time window 2 in the sensitivity cohort is stronger evidence of year-to-year change in median exacerbation rates, coinciding with the start of the pandemic.
← all excerpts
Effect of COVID-19 on Bronchiectasis Exacerbation Rates: A Retrospective U.S. Insurance Claims Study.
1
—
—